A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer

Clinical trial NCT00454532 · COMPLETED

Trial details

NCT number: NCT00454532
Sponsor: Bionovo
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2007-03-01
Primary completion: 2009-12-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.